APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biocidal Formulation

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biocidal Formulation Market Outlook and Growth Opportunities 2026

27 December 2025204 pages

Choose your research edition.

Industry ResearchBiocidal Formulation Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Biocidal Formulation Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Biocidal Formulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biocidal Formulation Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Biocidal Formulation Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Biocidal Formulation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biocidal Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biocidal Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biocidal Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biocidal Formulation market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biocidal Formulation market include Lanxess, Stepan Company, BASF SE, Bayer, Lonza, Ecolab, Solvay, DuPont and Dow Chemical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Biocidal Formulation market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biocidal Formulation and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biocidal Formulation sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biocidal Formulation market size, projected growth trends, production technologies, key applications, and end-use industries.

Biocidal Formulation Segment by Company

Lanxess

Stepan Company

BASF SE

Bayer

Lonza

Ecolab

Solvay

DuPont

Dow Chemical

Clariant

Evonik

Nufarm

Vink Chemicals

Corteva

Seipasa SA

FMC Corporation

Biocidal Formulation Segment by Type

Disinfectants

Preservatives

Others

Biocidal Formulation Segment by Application

Hospitals

Pharmaceuticals

Food and Beverage

Agriculture

Others

Biocidal Formulation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biocidal Formulation status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Biocidal Formulation market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biocidal Formulation significant trends, drivers, influence factors in global and regions.

6. To analyze Biocidal Formulation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biocidal Formulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biocidal Formulation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biocidal Formulation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biocidal Formulation market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biocidal Formulation industry.

Chapter 3: Detailed analysis of Biocidal Formulation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Biocidal Formulation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Biocidal Formulation in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biocidal Formulation Industry Trends Table 2. Biocidal Formulation Industry Drivers Table 3. Biocidal Formulation Industry Opportunities and Challenges Table 4. Biocidal Formulation Industry Restraints Table 5. Global Biocidal Formulation Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biocidal Formulation Revenue Share by Company (2021-2026) Table 7. Global Biocidal Formulation Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Biocidal Formulation Sales Volume Share by Company (2021-2026) Table 9. Global Biocidal Formulation Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Biocidal Formulation Company Ranking, (2024-2026) & (USD Million) Table 11. Global Biocidal Formulation Key Company Manufacturing Base & Headquarters Table 12. Global Biocidal Formulation Company, Product Type & Application Table 13. Global Biocidal Formulation Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Biocidal Formulation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Disinfectants Table 18. Significant Companies of Preservatives Table 19. Significant Companies of Others Table 20. Global Biocidal Formulation Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Biocidal Formulation Sales Volume by Type (2021-2026) & (Tons) Table 22. Global Biocidal Formulation Sales Volume by Type (2027-2032) & (Tons) Table 23. Global Biocidal Formulation Sales Volume Share by Type (2021-2026) Table 24. Global Biocidal Formulation Sales Volume Share by Type (2027-2032) Table 25. Global Biocidal Formulation Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Biocidal Formulation Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Biocidal Formulation Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Biocidal Formulation Sales Value Share by Type (2021-2026) Table 29. Global Biocidal Formulation Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Pharmaceuticals Table 32. Significant Companies of Food and Beverage Table 33. Significant Companies of Agriculture Table 34. Significant Companies of Others Table 35. Global Biocidal Formulation Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 36. Global Biocidal Formulation Sales Volume by Application (2021-2026) & (Tons) Table 37. Global Biocidal Formulation Sales Volume by Application (2027-2032) & (Tons) Table 38. Global Biocidal Formulation Sales Volume Share by Application (2021-2026) Table 39. Global Biocidal Formulation Sales Volume Share by Application (2027-2032) Table 40. Global Biocidal Formulation Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Biocidal Formulation Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Biocidal Formulation Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Biocidal Formulation Sales Value Share by Application (2021-2026) Table 44. Global Biocidal Formulation Sales Value Share by Application (2027-2032) Table 45. Global Biocidal Formulation Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 46. Global Biocidal Formulation Sales by Region (2021-2026) & (Tons) Table 47. Global Biocidal Formulation Sales Market Share by Region (2021-2026) Table 48. Global Biocidal Formulation Sales by Region (2027-2032) & (Tons) Table 49. Global Biocidal Formulation Sales Market Share by Region (2027-2032) Table 50. Global Biocidal Formulation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Biocidal Formulation Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Biocidal Formulation Sales Value Share by Region (2021-2026) Table 53. Global Biocidal Formulation Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Biocidal Formulation Sales Value Share by Region (2027-2032) Table 55. Global Biocidal Formulation Market Average Price (US$/Ton) by Region (2021-2026) Table 56. Global Biocidal Formulation Market Average Price (US$/Ton) by Region (2027-2032) Table 57. Global Biocidal Formulation Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 58. Global Biocidal Formulation Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Biocidal Formulation Sales by Country (2021-2026) & (Tons) Table 60. Global Biocidal Formulation Sales Market Share by Country (2021-2026) Table 61. Global Biocidal Formulation Sales by Country (2027-2032) & (Tons) Table 62. Global Biocidal Formulation Sales Market Share by Country (2027-2032) Table 63. Global Biocidal Formulation Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Biocidal Formulation Sales Value Market Share by Country (2021-2026) Table 65. Global Biocidal Formulation Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Biocidal Formulation Sales Value Market Share by Country (2027-2032) Table 67. Lanxess Company Information Table 68. Lanxess Business Overview Table 69. Lanxess Biocidal Formulation Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Lanxess Biocidal Formulation Product Portfolio Table 71. Lanxess Recent Development Table 72. Stepan Company Company Information Table 73. Stepan Company Business Overview Table 74. Stepan Company Biocidal Formulation Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Stepan Company Biocidal Formulation Product Portfolio Table 76. Stepan Company Recent Development Table 77. BASF SE Company Information Table 78. BASF SE Business Overview Table 79. BASF SE Biocidal Formulation Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. BASF SE Biocidal Formulation Product Portfolio Table 81. BASF SE Recent Development Table 82. Bayer Company Information Table 83. Bayer Business Overview Table 84. Bayer Biocidal Formulation Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Bayer Biocidal Formulation Product Portfolio Table 86. Bayer Recent Development Table 87. Lonza Company Information Table 88. Lonza Business Overview Table 89. Lonza Biocidal Formulation Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Lonza Biocidal Formulation Product Portfolio Table 91. Lonza Recent Development Table 92. Ecolab Company Information Table 93. Ecolab Business Overview Table 94. Ecolab Biocidal Formulation Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Ecolab Biocidal Formulation Product Portfolio Table 96. Ecolab Recent Development Table 97. Solvay Company Information Table 98. Solvay Business Overview Table 99. Solvay Biocidal Formulation Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Solvay Biocidal Formulation Product Portfolio Table 101. Solvay Recent Development Table 102. DuPont Company Information Table 103. DuPont Business Overview Table 104. DuPont Biocidal Formulation Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. DuPont Biocidal Formulation Product Portfolio Table 106. DuPont Recent Development Table 107. Dow Chemical Company Information Table 108. Dow Chemical Business Overview Table 109. Dow Chemical Biocidal Formulation Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. Dow Chemical Biocidal Formulation Product Portfolio Table 111. Dow Chemical Recent Development Table 112. Clariant Company Information Table 113. Clariant Business Overview Table 114. Clariant Biocidal Formulation Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 115. Clariant Biocidal Formulation Product Portfolio Table 116. Clariant Recent Development Table 117. Evonik Company Information Table 118. Evonik Business Overview Table 119. Evonik Biocidal Formulation Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 120. Evonik Biocidal Formulation Product Portfolio Table 121. Evonik Recent Development Table 122. Nufarm Company Information Table 123. Nufarm Business Overview Table 124. Nufarm Biocidal Formulation Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 125. Nufarm Biocidal Formulation Product Portfolio Table 126. Nufarm Recent Development Table 127. Vink Chemicals Company Information Table 128. Vink Chemicals Business Overview Table 129. Vink Chemicals Biocidal Formulation Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 130. Vink Chemicals Biocidal Formulation Product Portfolio Table 131. Vink Chemicals Recent Development Table 132. Corteva Company Information Table 133. Corteva Business Overview Table 134. Corteva Biocidal Formulation Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 135. Corteva Biocidal Formulation Product Portfolio Table 136. Corteva Recent Development Table 137. Seipasa SA Company Information Table 138. Seipasa SA Business Overview Table 139. Seipasa SA Biocidal Formulation Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 140. Seipasa SA Biocidal Formulation Product Portfolio Table 141. Seipasa SA Recent Development Table 142. FMC Corporation Company Information Table 143. FMC Corporation Business Overview Table 144. FMC Corporation Biocidal Formulation Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 145. FMC Corporation Biocidal Formulation Product Portfolio Table 146. FMC Corporation Recent Development Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Biocidal Formulation Distributors List Table 150. Biocidal Formulation Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Biocidal Formulation Product Image Figure 2. Global Biocidal Formulation Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biocidal Formulation Sales Value (2021-2032) & (US$ Million) Figure 4. Global Biocidal Formulation Sales (2021-2032) & (Tons) Figure 5. Global Biocidal Formulation Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Biocidal Formulation Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Disinfectants Image Figure 10. Preservatives Image Figure 11. Others Image Figure 12. Global Biocidal Formulation Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Biocidal Formulation Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Biocidal Formulation Sales Volume Share by Type (2021-2032) Figure 15. Global Biocidal Formulation Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Biocidal Formulation Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Biocidal Formulation Sales Value Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Pharmaceuticals Image Figure 20. Food and Beverage Image Figure 21. Agriculture Image Figure 22. Others Image Figure 23. Global Biocidal Formulation Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 24. Global Biocidal Formulation Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Biocidal Formulation Sales Volume Share by Application (2021-2032) Figure 26. Global Biocidal Formulation Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Biocidal Formulation Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Biocidal Formulation Sales Value Share by Application (2021-2032) Figure 29. Global Biocidal Formulation Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 30. Global Biocidal Formulation Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Biocidal Formulation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Biocidal Formulation Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Biocidal Formulation Sales Value (2021-2032) & (US$ Million) Figure 34. North America Biocidal Formulation Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Biocidal Formulation Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Biocidal Formulation Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Biocidal Formulation Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Biocidal Formulation Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Biocidal Formulation Sales Value (2021-2032) & (US$ Million) Figure 40. South America Biocidal Formulation Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Biocidal Formulation Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Biocidal Formulation Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Biocidal Formulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Biocidal Formulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Biocidal Formulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Biocidal Formulation Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Biocidal Formulation Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Disinfectants
  • Preservatives
  • Others
Applications
  • Hospitals
  • Pharmaceuticals
  • Food and Beverage
  • Agriculture
  • Others
Companies covered
  • Lanxess
  • Stepan Company
  • BASF SE
  • Bayer
  • Lonza
  • Ecolab
  • Solvay
  • DuPont
  • Dow Chemical
  • Clariant
  • Evonik
  • Nufarm
  • Vink Chemicals
  • Corteva
  • Seipasa SA
  • FMC Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biocidal Formulation Sales Value (2021-2032)
  4. 1.2.2 Global Biocidal Formulation Sales Volume (2021-2032)
  5. 1.2.3 Global Biocidal Formulation Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Biocidal Formulation Market Dynamics
  1. 2.1 Biocidal Formulation Industry Trends
  2. 2.2 Biocidal Formulation Industry Drivers
  3. 2.3 Biocidal Formulation Industry Opportunities and Challenges
  4. 2.4 Biocidal Formulation Industry Restraints
3 Biocidal Formulation Market by Company
  1. 3.1 Global Biocidal Formulation Company Revenue Ranking in 2025
  2. 3.2 Global Biocidal Formulation Revenue by Company (2021-2026)
  3. 3.3 Global Biocidal Formulation Sales Volume by Company (2021-2026)
  4. 3.4 Global Biocidal Formulation Average Price by Company (2021-2026)
  5. 3.5 Global Biocidal Formulation Company Ranking (2024-2026)
  6. 3.6 Global Biocidal Formulation Company Manufacturing Base and Headquarters
  7. 3.7 Global Biocidal Formulation Company Product Type and Application
  8. 3.8 Global Biocidal Formulation Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Biocidal Formulation Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Biocidal Formulation Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Biocidal Formulation Market by Type
  1. 4.1 Biocidal Formulation Type Introduction
  2. 4.1.1 Disinfectants
  3. 4.1.2 Preservatives
  4. 4.1.3 Others
  5. 4.2 Global Biocidal Formulation Sales Volume by Type
  6. 4.2.1 Global Biocidal Formulation Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Biocidal Formulation Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Biocidal Formulation Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Biocidal Formulation Sales Value by Type
  10. 4.3.1 Global Biocidal Formulation Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Biocidal Formulation Sales Value by Type (2021-2032)
  12. 4.3.3 Global Biocidal Formulation Sales Value Share by Type (2021-2032)
5 Biocidal Formulation Market by Application
  1. 5.1 Biocidal Formulation Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Pharmaceuticals
  4. 5.1.3 Food and Beverage
  5. 5.1.4 Agriculture
  6. 5.1.5 Others
  7. 5.2 Global Biocidal Formulation Sales Volume by Application
  8. 5.2.1 Global Biocidal Formulation Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Biocidal Formulation Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Biocidal Formulation Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Biocidal Formulation Sales Value by Application
  12. 5.3.1 Global Biocidal Formulation Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Biocidal Formulation Sales Value by Application (2021-2032)
  14. 5.3.3 Global Biocidal Formulation Sales Value Share by Application (2021-2032)
6 Biocidal Formulation Regional Sales and Value Analysis
  1. 6.1 Global Biocidal Formulation Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biocidal Formulation Sales by Region (2021-2032)
  3. 6.2.1 Global Biocidal Formulation Sales by Region: 2021-2026
  4. 6.2.2 Global Biocidal Formulation Sales by Region (2027-2032)
  5. 6.3 Global Biocidal Formulation Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Biocidal Formulation Sales Value by Region (2021-2032)
  7. 6.4.1 Global Biocidal Formulation Sales Value by Region: 2021-2026
  8. 6.4.2 Global Biocidal Formulation Sales Value by Region (2027-2032)
  9. 6.5 Global Biocidal Formulation Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Biocidal Formulation Sales Value (2021-2032)
  12. 6.6.2 North America Biocidal Formulation Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Biocidal Formulation Sales Value (2021-2032)
  15. 6.7.2 Europe Biocidal Formulation Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Biocidal Formulation Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Biocidal Formulation Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Biocidal Formulation Sales Value (2021-2032)
  21. 6.9.2 South America Biocidal Formulation Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Biocidal Formulation Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Biocidal Formulation Sales Value Share by Country, 2025 VS 2032
7 Biocidal Formulation Country-level Sales and Value Analysis
  1. 7.1 Global Biocidal Formulation Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biocidal Formulation Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Biocidal Formulation Sales by Country (2021-2032)
  4. 7.3.1 Global Biocidal Formulation Sales by Country (2021-2026)
  5. 7.3.2 Global Biocidal Formulation Sales by Country (2027-2032)
  6. 7.4 Global Biocidal Formulation Sales Value by Country (2021-2032)
  7. 7.4.1 Global Biocidal Formulation Sales Value by Country (2021-2026)
  8. 7.4.2 Global Biocidal Formulation Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Biocidal Formulation Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Biocidal Formulation Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Biocidal Formulation Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Biocidal Formulation Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Biocidal Formulation Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Biocidal Formulation Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Biocidal Formulation Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Biocidal Formulation Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Biocidal Formulation Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Biocidal Formulation Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Biocidal Formulation Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Biocidal Formulation Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Biocidal Formulation Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Biocidal Formulation Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Biocidal Formulation Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Biocidal Formulation Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Biocidal Formulation Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Biocidal Formulation Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Biocidal Formulation Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Biocidal Formulation Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Biocidal Formulation Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Biocidal Formulation Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Biocidal Formulation Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Biocidal Formulation Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Biocidal Formulation Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Biocidal Formulation Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Biocidal Formulation Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Biocidal Formulation Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Biocidal Formulation Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Biocidal Formulation Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lanxess
  2. 8.1.1 Lanxess Company Information
  3. 8.1.2 Lanxess Business Overview
  4. 8.1.3 Lanxess Biocidal Formulation Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Lanxess Biocidal Formulation Product Portfolio
  6. 8.1.5 Lanxess Recent Developments
  7. 8.2 Stepan Company
  8. 8.2.1 Stepan Company Company Information
  9. 8.2.2 Stepan Company Business Overview
  10. 8.2.3 Stepan Company Biocidal Formulation Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Stepan Company Biocidal Formulation Product Portfolio
  12. 8.2.5 Stepan Company Recent Developments
  13. 8.3 BASF SE
  14. 8.3.1 BASF SE Company Information
  15. 8.3.2 BASF SE Business Overview
  16. 8.3.3 BASF SE Biocidal Formulation Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 BASF SE Biocidal Formulation Product Portfolio
  18. 8.3.5 BASF SE Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer Biocidal Formulation Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Biocidal Formulation Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 Lonza
  26. 8.5.1 Lonza Company Information
  27. 8.5.2 Lonza Business Overview
  28. 8.5.3 Lonza Biocidal Formulation Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Lonza Biocidal Formulation Product Portfolio
  30. 8.5.5 Lonza Recent Developments
  31. 8.6 Ecolab
  32. 8.6.1 Ecolab Company Information
  33. 8.6.2 Ecolab Business Overview
  34. 8.6.3 Ecolab Biocidal Formulation Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Ecolab Biocidal Formulation Product Portfolio
  36. 8.6.5 Ecolab Recent Developments
  37. 8.7 Solvay
  38. 8.7.1 Solvay Company Information
  39. 8.7.2 Solvay Business Overview
  40. 8.7.3 Solvay Biocidal Formulation Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Solvay Biocidal Formulation Product Portfolio
  42. 8.7.5 Solvay Recent Developments
  43. 8.8 DuPont
  44. 8.8.1 DuPont Company Information
  45. 8.8.2 DuPont Business Overview
  46. 8.8.3 DuPont Biocidal Formulation Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 DuPont Biocidal Formulation Product Portfolio
  48. 8.8.5 DuPont Recent Developments
  49. 8.9 Dow Chemical
  50. 8.9.1 Dow Chemical Company Information
  51. 8.9.2 Dow Chemical Business Overview
  52. 8.9.3 Dow Chemical Biocidal Formulation Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Dow Chemical Biocidal Formulation Product Portfolio
  54. 8.9.5 Dow Chemical Recent Developments
  55. 8.10 Clariant
  56. 8.10.1 Clariant Company Information
  57. 8.10.2 Clariant Business Overview
  58. 8.10.3 Clariant Biocidal Formulation Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Clariant Biocidal Formulation Product Portfolio
  60. 8.10.5 Clariant Recent Developments
  61. 8.11 Evonik
  62. 8.11.1 Evonik Company Information
  63. 8.11.2 Evonik Business Overview
  64. 8.11.3 Evonik Biocidal Formulation Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Evonik Biocidal Formulation Product Portfolio
  66. 8.11.5 Evonik Recent Developments
  67. 8.12 Nufarm
  68. 8.12.1 Nufarm Company Information
  69. 8.12.2 Nufarm Business Overview
  70. 8.12.3 Nufarm Biocidal Formulation Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Nufarm Biocidal Formulation Product Portfolio
  72. 8.12.5 Nufarm Recent Developments
  73. 8.13 Vink Chemicals
  74. 8.13.1 Vink Chemicals Company Information
  75. 8.13.2 Vink Chemicals Business Overview
  76. 8.13.3 Vink Chemicals Biocidal Formulation Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Vink Chemicals Biocidal Formulation Product Portfolio
  78. 8.13.5 Vink Chemicals Recent Developments
  79. 8.14 Corteva
  80. 8.14.1 Corteva Company Information
  81. 8.14.2 Corteva Business Overview
  82. 8.14.3 Corteva Biocidal Formulation Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Corteva Biocidal Formulation Product Portfolio
  84. 8.14.5 Corteva Recent Developments
  85. 8.15 Seipasa SA
  86. 8.15.1 Seipasa SA Company Information
  87. 8.15.2 Seipasa SA Business Overview
  88. 8.15.3 Seipasa SA Biocidal Formulation Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Seipasa SA Biocidal Formulation Product Portfolio
  90. 8.15.5 Seipasa SA Recent Developments
  91. 8.16 FMC Corporation
  92. 8.16.1 FMC Corporation Company Information
  93. 8.16.2 FMC Corporation Business Overview
  94. 8.16.3 FMC Corporation Biocidal Formulation Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 FMC Corporation Biocidal Formulation Product Portfolio
  96. 8.16.5 FMC Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Biocidal Formulation Value Chain Analysis
  2. 9.1.1 Biocidal Formulation Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Biocidal Formulation Sales Mode & Process
  6. 9.2 Biocidal Formulation Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Biocidal Formulation Distributors
  9. 9.2.3 Biocidal Formulation Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst